NCT03187236 is a clinical trial in COPD, sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital.

Who is sponsoring NCT03187236?

NCT03187236 is sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital.

What condition does NCT03187236 study?

NCT03187236 studies COPD, Anxiety, Depression.

Is NCT03187236 still recruiting?

NCT03187236 is currently status unknown. Last updated 14 June 2017.

Last reviewed 2017-06-14 · How we verify

NCT03187236

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China

Status unknown Last updated 14 June 2017

What this trial tests

trial in COPD in 1,906 participants. Status unknown.

Timeline

15 June 2017

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Chinese Academy of Medical Sciences, Fuwai Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,906
Start date	15 June 2017
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across China

Conditions studied

COPD — all drugs for COPD →
Anxiety — all drugs for Anxiety →
Depression — all drugs for Depression →

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Who can join

Under 80, any sex, with COPD or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD). However, the exact prevalence is not known in China. COPD patients with anxiety and depression tend to have more severe symptoms and worse prognosis, but the related evidences are not strong enough. The study aim to investigate the prevalence and long-term outcome of anxiety and depression in COPD.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
Zhao X, Su R, Hu R, Chen Y, et al · · 2023 · cited 22× · PMID 36774462 · DOI 10.1186/s12877-023-03784-7
Clinical and economic burden of anxiety/depression among older adult COPD patients: evidence from the COPD-AD China Registry study.
Zhao X, Liu G, Liu D, Zou L, et al · · 2023 · cited 8× · PMID 38260779 · DOI 10.3389/fpsyt.2023.1221767
Exploring the Relationship Between Education, Living Environment, and Anxiety/Depression Among Stable Patients: Insights from the COPD-AD China Registry Study.
Wu D, Long B, Huang B, Zhong X, et al · · 2024 · cited 2× · PMID 39346627 · DOI 10.2147/copd.s455923
The predictive value of D-dimer combined with systemic immune-inflammation index for the presence of pulmonary thromboembolism in AECOPD patients.
Zhao X, Li J, Wang Y, Huang B, et al · · 2025 · PMID 40823589 · DOI 10.3389/fmed.2025.1582913
Exploring the relationship between education, living environment, and anxiety/depression among stable patients: insights from the COPD-AD China Registry study
Zhao X, Long B, Huang B, Zhong X, et al · · 2023 · DOI 10.21203/rs.3.rs-2877766/v1

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Chinese Academy of Medical Sciences, Fuwai Hospital trials

Trials by the same sponsor.

NCT07450196 — A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Val · not yet recruiting
NCT07511309 — FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis: A Randomized Controlled Trial · NA · not yet recruiting
NCT07054541 — A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire · Phase 4 · not yet recruiting
NCT07458672 — TAVR for Aortic Regurgitation Under TTE Guidance · NA · not yet recruiting
NCT07462325 — Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03187236 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese Academy of Medical Sciences, Fuwai Hospital
Last refreshed: 14 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03187236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing